Lisa Ricciardi has joined Essex Woodlands Health Ventures as an adjunct partner. She previously was with Pfizer as senior vice president of licensing and development.
Essex Woodlands Health Ventures, a leading venture capital firm solely dedicated to healthcare investing, announces the addition of Lisa Ricciardi, former SVP of Licensing and Development with Pfizer, to the New York office.
Most recently, Ms. Ricciardi led the overall licensing and negotiations of complex, multinational, multiyear deals with global research-based pharmaceutical firms in North America, Japan and Europe. Under her leadership, the group licensed a significant number of early and late stage assets. She began her 19 year Pfizer career in 1988 as a Product Manager, launching $3B Norvasc, Pfizer's first internal competitor to its own $1B category leader. As Team Leader and Group Leader, Ms. Ricciardi led the expansion of the anti-infectives portfolio, positioning and commercializing new drugs. In 1998, Ms. Ricciardi was promoted to Vice President and Corporate Officer when she took over responsibility for Licensing and Developing. In 2004, she was promoted to Senior Vice President.
As an Adjunct Partner at Essex Woodlands Health Ventures, Ms. Ricciardi will provide marketing and commercialization expertise to EWHV portfolio companies. In addition, she will identify new opportunities and participate in evaluating potential investments. “I look forward to working closely with EWHV and their portfolio companies to create industry-leading companies. Part of my interest in joining is Essex Woodlands' track record of creating value over the long term in their companies.”
Ms. Ricciardi will operate from the firm's New York City office. Managing Director Mark Pacala said on her appointment, “Lisa will provide critically important skills and capabilities to our portfolio companies. She brings a wealth of talent and experience to our global firm.” Ms. Ricciardi holds a B.A. with honors from Wesleyan University and an MBA from the University of Chicago.
About Essex Woodlands Health Ventures
Essex Woodlands is one of the largest and oldest venture capital firms pursuing investments in pharmaceuticals, biotechnology, medical devices, health services, managed care and health information. Since its founding in 1985, Essex Woodlands has maintained its singular commitment to the healthcare industry and has been involved in the founding, investing, and/or management of over 100 healthcare companies ranging across all sectors, stages and geography. The team is comprised of 20+ investment professionals with principal offices in Palo Alto, California; Houston, Texas; New York City; and London, United Kingdom. For more information, please see